Published in J Virol on January 01, 2010
Uncovering the mysteries of hantavirus infections. Nat Rev Microbiol (2013) 1.75
Electron cryotomography of Tula hantavirus suggests a unique assembly paradigm for enveloped viruses. J Virol (2010) 1.33
Hantaviruses in the americas and their role as emerging pathogens. Viruses (2010) 1.02
Acid-activated structural reorganization of the Rift Valley fever virus Gc fusion protein. J Virol (2012) 1.00
An assembly model of rift valley Fever virus. Front Microbiol (2012) 0.97
Interaction of hantavirus nucleocapsid protein with ribosomal protein S19. J Virol (2010) 0.93
A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2. J Biol Chem (2012) 0.87
The Structure of the Hantavirus Zinc Finger Domain is Conserved and Represents the Only Natively Folded Region of the Gn Cytoplasmic Tail. Front Microbiol (2011) 0.87
Autophagic clearance of Sin Nombre hantavirus glycoprotein Gn promotes virus replication in cells. J Virol (2012) 0.85
Time-resolved FRET -based approach for antibody detection - a new serodiagnostic concept. PLoS One (2013) 0.84
Hantavirus Gn and Gc envelope glycoproteins: key structural units for virus cell entry and virus assembly. Viruses (2014) 0.84
A Molecular-Level Account of the Antigenic Hantaviral Surface. Cell Rep (2016) 0.82
Inhibition of the Hantavirus Fusion Process by Predicted Domain III and Stem Peptides from Glycoprotein Gc. PLoS Negl Trop Dis (2016) 0.79
Crystal Structure of Glycoprotein C from a Hantavirus in the Post-fusion Conformation. PLoS Pathog (2016) 0.78
The use of chimeric virus-like particles harbouring a segment of hantavirus Gc glycoprotein to generate a broadly-reactive hantavirus-specific monoclonal antibody. Viruses (2014) 0.76
The role of viral genomic RNA and nucleocapsid protein in the autophagic clearance of hantavirus glycoprotein Gn. Virus Res (2014) 0.76
Identification of linear human B-cell epitopes of tick-borne encephalitis virus. Virol J (2014) 0.75
Structural transitions of the conserved and metastable hantaviral glycoprotein envelope. J Virol (2017) 0.75
The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics (2005) 34.83
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
TM-align: a protein structure alignment algorithm based on the TM-score. Nucleic Acids Res (2005) 14.15
The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature (1995) 12.25
Hantaviruses: a global disease problem. Emerg Infect Dis (1997) 9.67
Cryo-electron microscopy of viruses. Nature (1984) 6.80
Tables for estimating sedimentation through linear concentration gradients of sucrose solution. Anal Biochem (1967) 6.48
The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell (2001) 5.65
Hantavirus infections in Europe. Lancet Infect Dis (2003) 5.27
The many mechanisms of viral membrane fusion proteins. Curr Top Microbiol Immunol (2005) 4.19
VADAR: a web server for quantitative evaluation of protein structure quality. Nucleic Acids Res (2003) 3.95
Studies in subviral components of Semliki Forest virus. Ann Med Exp Biol Fenn (1969) 3.59
The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports--principles and applications. J Immunol Methods (2002) 3.52
Location of the spike glycoproteins in the Semliki Forest virus membrane. Proc Natl Acad Sci U S A (1974) 3.10
Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G. Science (2007) 2.97
Locations of carbohydrate sites on alphavirus glycoproteins show that E1 forms an icosahedral scaffold. Cell (2001) 2.96
The protein disulphide-isomerase family: unravelling a string of folds. Biochem J (1999) 2.64
Average protein density is a molecular-weight-dependent function. Protein Sci (2004) 2.62
Hantaviruses: genome structure, expression and evolution. J Gen Virol (1996) 2.47
Envelope structure of Semliki Forest virus reconstructed from cryo-electron micrographs. Nature (1986) 2.35
Virus evolution and genetic diversity of hantaviruses and their rodent hosts. Curr Top Microbiol Immunol (2001) 2.16
Solubilization of the membrane proteins from Semliki Forest virus with Triton X100. J Mol Biol (1973) 2.09
Peptide arrays on cellulose support: SPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion. Nat Protoc (2007) 2.08
Structure and interactions at the viral surface of the envelope protein E1 of Semliki Forest virus. Structure (2006) 2.05
Isomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion. EMBO J (2003) 1.93
Prolonged survival of Puumala hantavirus outside the host: evidence for indirect transmission via the environment. J Gen Virol (2006) 1.86
Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response. J Med Virol (1995) 1.61
Assembly of coronavirus spike protein into trimers and its role in epitope expression. J Virol (1990) 1.60
Formation and intracellular transport of a heterodimeric viral spike protein complex. J Cell Biol (1991) 1.58
Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies. J Gen Virol (1989) 1.58
Cloning and sequencing of Puumala virus Sotkamo strain S and M RNA segments: evidence for strain variation in hantaviruses and expression of the nucleocapsid protein. J Gen Virol (1992) 1.58
Cross-linking of the spike glycoproteins in Semliki Forest virus with dimethylsuberimidate. Virology (1974) 1.52
Hantaviruses: molecular biology, evolution and pathogenesis. Curr Mol Med (2005) 1.49
Intracellular and viral membrane fusion: a uniting mechanism. Curr Opin Cell Biol (2004) 1.43
Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes). Theor Biol Med Model (2004) 1.41
Bank vole monoclonal antibodies against Puumala virus envelope glycoproteins: identification of epitopes involved in neutralization. Arch Virol (1992) 1.39
Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis. Virology (2002) 1.36
The organization of the spike complex of Semliki Forest virus. J Mol Biol (1994) 1.30
Acid-resistant bovine pestivirus requires activation for pH-triggered fusion during entry. J Virol (2005) 1.28
How to diagnose hantavirus infections and detect them in rodents and insectivores. Rev Med Virol (2008) 1.26
The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA. Virology (2001) 1.23
Sin Nombre virus glycoprotein trafficking. Virology (2003) 1.17
Architecture of the SARS coronavirus prefusion spike. Nat Struct Mol Biol (2006) 1.16
Golgi localization of Hantaan virus glycoproteins requires coexpression of G1 and G2. Virology (2002) 1.08
Distinction between Bunyaviridae genera by surface structure and comparison with Hantaan virus using negative stain electron microscopy. Arch Virol (1985) 1.04
Epitope mapping studies with neutralizing and non-neutralizing monoclonal antibodies to the G1 and G2 envelope glycoproteins of Hantaan virus. Virology (1993) 1.04
Hantavirus Gc glycoprotein: evidence for a class II fusion protein. J Gen Virol (2005) 1.04
Homodimeric association of the spike glycoproteins G1 and G2 of Uukuniemi virus. Virology (1995) 1.03
Cell fusion activities of Hantaan virus envelope glycoproteins. J Virol (2004) 1.01
Coexpression of the membrane glycoproteins G1 and G2 of Hantaan virus is required for targeting to the Golgi complex. Virology (1992) 1.00
Human recombinant neutralizing antibodies against hantaan virus G2 protein. Virology (2003) 0.96
Phage-displayed peptides mimicking the discontinuous neutralization sites of puumala Hantavirus envelope glycoproteins. Virology (1999) 0.94
Primary cell cultures from murine kidney and heart differ in endosomal pH. J Cell Physiol (1998) 0.93
Prefusion rearrangements resulting in fusion Peptide exposure in Semliki forest virus. J Biol Chem (2002) 0.91
The Hantaan virus M-segment glycoproteins G1 and G2 can be expressed independently. J Virol (1992) 0.89
Hantavirus maturation. Curr Top Microbiol Immunol (2001) 0.89
Single amino acid substitutions in Puumala virus envelope glycoproteins G1 and G2 eliminate important neutralization epitopes. Virus Res (1997) 0.89
Neutralizing human monoclonal antibodies against Puumala virus, causative agent of nephropathia epidemica: a novel method using antigen-coated magnetic beads for specific B cell isolation. J Gen Virol (1993) 0.88
Interactions and trafficking of Andes and Sin Nombre Hantavirus glycoproteins G1 and G2. Virology (2005) 0.88
The dynamic envelope of a fusion class II virus. E3 domain of glycoprotein E2 precursor in Semliki Forest virus provides a unique contact with the fusion protein E1. J Biol Chem (2008) 0.86
Reversible fast-dimerization of bovine serum albumin detected by fluorescence resonance energy transfer. Biochim Biophys Acta (2002) 0.86
Transdominant inhibition of bovine viral diarrhea virus entry. J Virol (2007) 0.83
Low pH-induced cytopathic effect--a survey of seven hantavirus strains. J Virol Methods (1999) 0.83
Defining the N-linked glycosylation site of Hantaan virus envelope glycoproteins essential for cell fusion. J Microbiol (2007) 0.81
Tobacco mosaic virus: a model antigen to study virus-antibody interactions. Biochimie (1993) 0.80
Phage-displayed peptide targeting on the Puumala hantavirus neutralization site. J Virol (1997) 0.80
Anti-idiotypic antibodies against Puumala virus glycoprotein-specific monoclonal antibodies inhibit virus infection in cell cultures. Arch Virol (1993) 0.80
Mapping of viral conformational epitopes using biosensor measurements. J Immunol Methods (1995) 0.79
Hantavirus infections in Europe. Lancet Infect Dis (2003) 5.27
Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A (2006) 2.51
Activation of fibroblasts in cancer stroma. Exp Cell Res (2010) 2.19
The Yersinia adhesin YadA collagen-binding domain structure is a novel left-handed parallel beta-roll. EMBO J (2004) 2.15
Complement inhibitor factor H binding to Lyme disease spirochetes is mediated by inducible expression of multiple plasmid-encoded outer surface protein E paralogs. J Immunol (2002) 2.06
Prolonged survival of Puumala hantavirus outside the host: evidence for indirect transmission via the environment. J Gen Virol (2006) 1.86
Uncovering the mysteries of hantavirus infections. Nat Rev Microbiol (2013) 1.75
Beta2 integrin phosphorylation on Thr758 acts as a molecular switch to regulate 14-3-3 and filamin binding. Blood (2008) 1.66
Structural determinants of growth factor binding and specificity by VEGF receptor 2. Proc Natl Acad Sci U S A (2010) 1.60
Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck. Int J Cancer (2003) 1.57
Cowpox with severe generalized eruption, Finland. Emerg Infect Dis (2003) 1.55
Cyclic hantavirus epidemics in humans--predicted by rodent host dynamics. Epidemics (2009) 1.53
Isolation, identification, and characterization of novel arenaviruses, the etiological agents of boid inclusion body disease. J Virol (2013) 1.35
Long-lived memory T lymphocyte responses after hantavirus infection. J Exp Med (2002) 1.34
Electron cryotomography of Tula hantavirus suggests a unique assembly paradigm for enveloped viruses. J Virol (2010) 1.33
Tula and Puumala hantavirus NSs ORFs are functional and the products inhibit activation of the interferon-beta promoter. J Med Virol (2007) 1.32
Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization. Cancer Cell (2010) 1.32
Hypophyseal hemorrhage and panhypopituitarism during Puumala Virus Infection: Magnetic Resonance Imaging and detection of viral antigen in the hypophysis. Clin Infect Dis (2002) 1.31
Siberian subtype tickborne encephalitis virus, Finland. Emerg Infect Dis (2006) 1.28
Tula hantavirus triggers pro-apoptotic signals of ER stress in Vero E6 cells. Virology (2005) 1.27
Characterization of a novel flavivirus from mosquitoes in northern europe that is related to mosquito-borne flaviviruses of the tropics. J Virol (2009) 1.26
Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer. Hum Pathol (2008) 1.25
Mapping of the regions involved in homotypic interactions of Tula hantavirus N protein. J Virol (2003) 1.22
Lysine-dependent multipoint binding of the Borrelia burgdorferi virulence factor outer surface protein E to the C terminus of factor H. J Immunol (2004) 1.20
Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients. Gynecol Oncol (2003) 1.19
Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism. J Infect Dis (2002) 1.18
Oligomerization of Hantavirus N protein: C-terminal alpha-helices interact to form a shared hydrophobic space. J Virol (2004) 1.18
Maternal antibodies postpone hantavirus infection and enhance individual breeding success. Proc Biol Sci (2006) 1.15
Complex evolution and epidemiology of Dobrava-Belgrade hantavirus: definition of genotypes and their characteristics. Arch Virol (2012) 1.15
Non-covalent interaction between nucleocapsid protein of Tula hantavirus and small ubiquitin-related modifier-1, SUMO-1. Virus Res (2003) 1.14
Phylogenetic evidence for host switching in the evolution of hantaviruses carried by Apodemus mice. Virus Res (2002) 1.12
Endemic hantavirus infection impairs the winter survival of its rodent host. Ecology (2007) 1.12
Human parvovirus B19 infection during pregnancy--value of modern molecular and serological diagnostics. J Clin Virol (2005) 1.12
Causative agent of Pogosta disease isolated from blood and skin lesions. Emerg Infect Dis (2004) 1.10
Hantavirus nucleocapsid protein interacts with the Fas-mediated apoptosis enhancer Daxx. J Gen Virol (2002) 1.10
Transfection-mediated generation of functionally competent Tula hantavirus with recombinant S RNA segment. EMBO J (2002) 1.09
Tick-borne encephalitis virus in wild rodents in winter, Finland, 2008-2009. Emerg Infect Dis (2011) 1.09
Hantavirus infections in fluctuating host populations: the role of maternal antibodies. Proc Biol Sci (2010) 1.08
Human CD8+ T cell memory generation in Puumala hantavirus infection occurs after the acute phase and is associated with boosting of EBV-specific CD8+ memory T cells. J Immunol (2007) 1.08
Clinical and laboratory manifestations of Sindbis virus infection: prospective study, Finland, 2002-2003. J Infect Dis (2005) 1.06
Characterization of recombinant amino-terminal NC4 domain of human collagen IX: interaction with glycosaminoglycans and cartilage oligomeric matrix protein. J Biol Chem (2004) 1.05
Urinary excretion of interleukin-6 correlates with proteinuria in acute Puumala hantavirus-induced nephritis. Am J Kidney Dis (2004) 1.05
Adaptation of Puumala hantavirus to cell culture is associated with point mutations in the coding region of the L segment and in the noncoding regions of the S segment. J Virol (2003) 1.04
Hantavirus infections in Europe: from virus carriers to a major public-health problem. Expert Rev Anti Infect Ther (2009) 1.04
The degree of leukocytosis and urine GATA-3 mRNA levels are risk factors for severe acute kidney injury in Puumala virus nephropathia epidemica. PLoS One (2012) 1.04
Acute central nervous system complications in varicella zoster virus infections. J Clin Virol (2002) 1.04
Orthopox virus infections in Eurasian wild rodents. Vector Borne Zoonotic Dis (2011) 1.04
European subtype tick-borne encephalitis virus in Ixodes persulcatus ticks. Emerg Infect Dis (2011) 1.03
TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes. J Dermatol Sci (2010) 1.02
Immune responses to Puumala virus infection and the pathogenesis of nephropathia epidemica. Microbes Infect (2004) 1.01
Tula hantavirus L protein is a 250 kDa perinuclear membrane-associated protein. J Gen Virol (2004) 1.01
Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness. Cancer Res (2005) 1.01
Enhanced thrombin formation and fibrinolysis during acute Puumala hantavirus infection. Thromb Res (2010) 1.01
Generation of recombinant vaccinia viruses expressing Puumala virus proteins and use in isolating cytotoxic T cells specific for Puumala virus. Virus Res (2002) 1.01
Expression of complement factor H binding immunoevasion proteins in Borrelia garinii isolated from patients with neuroborreliosis. Eur J Immunol (2005) 1.00
Formation and activation of fibroblast spheroids depend on fibronectin-integrin interaction. Exp Cell Res (2008) 1.00
Ezrin in primary cutaneous melanoma. Mod Pathol (2005) 0.99
Tula hantavirus infection of Vero E6 cells induces apoptosis involving caspase 8 activation. J Gen Virol (2004) 0.99
Oligomerization of hantavirus nucleocapsid protein: analysis of the N-terminal coiled-coil domain. J Virol (2006) 0.99
Central nervous system-related symptoms and findings are common in acute Puumala hantavirus infection. Ann Med (2010) 0.99
Hantavirus structure--molecular interactions behind the scene. J Gen Virol (2012) 0.98
Tick-borne encephalitis virus in ticks in Finland, Russian Karelia and Buryatia. J Gen Virol (2010) 0.98
Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue. J Clin Microbiol (2005) 0.97
Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system. Thromb Haemost (2004) 0.97
Molecular epidemiology of outbreak-associated and wild-waterfowl-derived newcastle disease virus strains in Finland, including a novel class I genotype. J Clin Microbiol (2012) 0.97
Alcohol, smoking and human papillomavirus in laryngeal carcinoma: a Nordic prospective multicenter study. J Cancer Res Clin Oncol (2007) 0.95
Pathology of Puumala hantavirus infection in macaques. PLoS One (2008) 0.95
Clustering of fibroblasts induces proinflammatory chemokine secretion promoting leukocyte migration. Mol Immunol (2009) 0.95
Detection of human orthopoxvirus infections and differentiation of smallpox virus with real-time PCR. J Med Virol (2009) 0.95
Merlin links to the cAMP neuronal signaling pathway by anchoring the RIbeta subunit of protein kinase A. J Biol Chem (2003) 0.95
Vascular endothelial growth factor (VEGF)/VEGF-C mosaic molecules reveal specificity determinants and feature novel receptor binding patterns. J Biol Chem (2006) 0.94
Characterization of collagenous peptides bound to lysyl hydroxylase isoforms. J Biol Chem (2004) 0.94
Platelet ligands and ADAMTS13 during Puumala hantavirus infection and associated thrombocytopenia. Blood Coagul Fibrinolysis (2011) 0.94
Identification of Seoul hantavirus in Rattus norvegicus in Indonesia. Scand J Infect Dis (2004) 0.94
Environmental change and disease dynamics: effects of intensive forest management on Puumala hantavirus infection in boreal bank vole populations. PLoS One (2012) 0.93
Interaction between hantaviral nucleocapsid protein and the cytoplasmic tail of surface glycoprotein Gn. Virus Res (2010) 0.93
Rhinovirus in adenoid tissue. Int J Pediatr Otorhinolaryngol (2004) 0.92
Molecular epidemiology of dengue virus strains from Finnish travelers. Emerg Infect Dis (2008) 0.92
Complement activation in Puumala hantavirus infection correlates with disease severity. Ann Med (2011) 0.92
High activity of indoleamine 2,3-dioxygenase is associated with renal insufficiency in Puumala hantavirus induced nephropathia epidemica. J Med Virol (2011) 0.92
Spatial and temporal dynamics of lymphocytic choriomeningitis virus in wild rodents, northern Italy. Emerg Infect Dis (2009) 0.92
Rodent-borne hemorrhagic fevers: under-recognized, widely spread and preventable - epidemiology, diagnostics and treatment. Crit Rev Microbiol (2012) 0.91
Serological evidence for Borna disease virus infection in humans, wild rodents and other vertebrates in Finland. J Clin Virol (2006) 0.91
Prefusion rearrangements resulting in fusion Peptide exposure in Semliki forest virus. J Biol Chem (2002) 0.91
Novel orthoreovirus from diseased crow, Finland. Emerg Infect Dis (2007) 0.91
Saaremaa hantavirus in Denmark. J Clin Virol (2004) 0.91
Human papillomavirus in larynx. Laryngoscope (2002) 0.90
Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system. Mol Cell Neurosci (2005) 0.90
Diagnostic rapid tests for acute hantavirus infections: specific tests for Hantaan, Dobrava and Puumala viruses versus a hantavirus combination test. J Virol Methods (2003) 0.90
Association between the DQA MHC class II gene and Puumala virus infection in Myodes glareolus, the bank vole. Infect Genet Evol (2007) 0.90
Human papillomavirus type 16 in head and neck carcinogenesis. Rev Med Virol (2005) 0.90